| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.49 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.066 | 0.2 |